Back to search
FDAFDA · Food and drugs·Recall number D-0928-2017

BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10

Published July 5, 2017 · Recall initiated: May 30, 2017

Summary

FDA records drug Class III recall D-0928-2017, published July 5, 2017 and initiated May 30, 2017. Recalling firm: Mckesson Packaging Services; Status: Terminated; Reported quantity: 942 cartons; Lot: Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Moisture Limits: Product tested out-of-specification for moisture content.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mckesson Packaging Services
Distributor
Nationwide in the US
Lot
Lot # 0113148, 0113149, 0113150, Exp: 04/18; 0113636, Exp: 06/18; 0114513, Exp: 10/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BuPROPion HCL Tablets, USP, 75 mg, packaged as UD 100 tablets (10x10), Rx Only, Mfg by: Sandoz Inc., 508 Carnegie Center, Suite 400, Princeton, NJ 08805, NDC: 63739-706-10 recalled?

Yes. FDA published recall D-0928-2017 on July 5, 2017. Reported hazard: Failed Moisture Limits: Product tested out-of-specification for moisture content.

What should I do if I have this product?

Voluntary: Firm initiated · Letter